EPS Creative Health Technology Group Ltd.

Media Center

2023's News

2023/12/22
FEF Pharmaceutical
The enrolment of patients has been initiated in the investigator-initiated clinical trials to which FEF Pharmaceutical Co., Ltd. provides investigational drugs
2023/12/21
FEF Pharmaceutical
Be selected as a FINALIST at 2023 JINJI LAKE Innovation & Entrepreneurship Competition
2023/11/15
EPS Innovative Medicine
Patients with allergic rhinitis and allergic to cedar pollinosis have lower saliva-secretory IgA than healthy subjects
2023/09/29
EPD
Concluded a joint research agreement with C-HAS+ Co., Ltd. for exploring useful substances for anti-obesity contained in natural products
2023/09/25
EPS Innovative Medicine
Having prospect for the development of simple, highly effective and safe sublingual vaccines
2023/06/16
EPD
Joint R&D Agreement for Regenerative Medicine Using Brown Adipocytes(for Slimming/weight loss)Concluded with Medical Corporation Tomoshibikai FIRE CLINIC
2023/06/06
Group Announcement
Notice of organization chart update (Addition of New Subsidiaries to “EPS Healthcare Ltd.”)
2023/02/21
FEF Pharmaceutical
FEF Pharmaceutical Co., Ltd. and Kyoto University have initiated a collaborative research project aimed at developing a novel treatment for lower extremity artery disease (LEAD)
This site is registered on wpml.org as a development site.